Home Sarepta Therapeutics Announces Plans To Submit Rolling NDA For Eteplirsen Following Today's Pre-NDA Meeting With The FDA
 

Keywords :   


Sarepta Therapeutics Announces Plans To Submit Rolling NDA For Eteplirsen Following Today's Pre-NDA Meeting With The FDA

2015-06-03 06:47:48| drugdiscoveryonline Home Page

Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics, recently announced that the Company held a pre-New Drug Application (NDA) meeting with the U.S

Tags: the with submit plans

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »